-
1
المؤلفون: Butt, Jawad H., Jhund, Pardeep S., Belohlavek, Jan, de Boer, Rudolf A., Chiang, Chern-En, Desai, Akshai S., Drozdz, Jaroslaw, Hernandez, Adrian F., Inzucchi, Silvio E., Katova, Tzvetana, Kitakaze, Masafumi, Kosiborod, Mikhail N., Lam, Carolyn S. P., Maria Langkilde, Anna, Lindholm, Daniel, Bachus, Erasmus, Martinez, Felipe, Merkely, Bela, Petersson, Magnus, Saraiva, Jose F. Kerr, Shah, Sanjiv J., Vaduganathan, Muthiah, Vardeny, Orly, Wilderang, Ulrica, Claggett, Brian L., Solomon, Scott D., McMurray, John J. V.
المصدر: Circulation. 146(16):1210-1224
مصطلحات موضوعية: *Benzhydryl Compounds/adverse effects, *Frailty/epidemiology, *Glucosides/adverse effects, *Heart Failure/drug therapy, clinical trial, dapagliflozin, frailty, heart failure, Humans, Quality of Life, Stroke Volume
وصف الملف: print
-
2
المؤلفون: Solomon, Scott D., McMurray, John J. V., Claggett, Brian, de Boer, Rudolf A., DeMets, David, Hernandez, Adrian F., Inzucchi, Silvio E., Kosiborod, Mikhail N., Lam, Carolyn S. P., Martinez, Felipe, Shah, Sanjiv J., Desai, Akshay S., Jhund, Pardeep S., Belohlavek, Jan, Chiang, Chern-En, Borleffs, C. Jan Willem, Comin-Colet, Josep, Dobreanu, Dan, Drozdz, Jaroslaw, Fang, James C., Alcocer-Gamba, Marco Antonio, Al Habeeb, Waleed, Han, Yaling, Cabrera Honorio, Jose Walter, Janssens, Stefan P., Katova, Tzvetana, Kitakaze, Masafumi, Merkely, Bela, O’Meara, Eileen, Saraiva, Jose Francisco Kerr, Tereshchenko, Sergey N., Thierer, Jorge, Vaduganathan, Muthiah, Vardeny, Orly, Verma, Subodh, Pham, Vinh Nguyen, Wilderang, Ulrica, Zaozerska, Natalia, Bachus, Erasmus, Lindholm, Daniel, Petersson, Magnus, Langkilde, Anna Maria
المصدر: The New England journal of medicine. 387(12):1089-1098
مصطلحات موضوعية: *Heart Failure/complications/drug therapy/mortality/physiopathology, *Sodium-Glucose Transporter 2 Inhibitors/adverse effects/pharmacology/therapeutic use, *Stroke Volume/drug effects, *Ventricular Function, Left/drug effects, Benzhydryl Compounds/adverse effects/therapeutic use, Diabetes Mellitus, Type 2/complications/drug therapy, Glucosides/adverse effects/therapeutic use, Humans
وصف الملف: print
-
3
المؤلفون: Massar Omar, Jesper Jensen, Caroline Kistorp, Kurt Højlund, Lars Videbæk, Christian Tuxen, Julie H. Larsen, Camilla F. Andersen, Finn Gustafsson, Lars Køber, Morten Schou, Jacob Eifer Møller
المصدر: Omar, M, Jensen, J, Kistorp, C, Højlund, K, Videbæk, L, Tuxen, C, Larsen, J H, Andersen, C F, Gustafsson, F, Køber, L, Schou, M & Møller, J E 2022, ' The effect of empagliflozin on growth differentiation factor 15 in patients with heart failure : a randomized controlled trial (Empire HF Biomarker) ', Cardiovascular Diabetology, vol. 21, 34 . https://doi.org/10.1186/s12933-022-01463-2
Omar, M, Jensen, J, Kistorp, C, Højlund, K, Videbæk, L, Tuxen, C, Larsen, J H, Andersen, C F, Gustafsson, F, Køber, L, Schou, M & Møller, J E 2022, ' The effect of empagliflozin on growth differentiation factor 15 in patients with heart failure : a randomized controlled trial (Empire HF Biomarker) ', Cardiovascular Diabetology, vol. 21, no. 1, 34 . https://doi.org/10.1186/s12933-022-01463-2مصطلحات موضوعية: Heart Failure, Male, Diabetes Mellitus, Type 2/chemically induced, Growth Differentiation Factor 15, Endocrinology, Diabetes and Metabolism, Benzhydryl Compounds/adverse effects, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Stroke Volume, HFrEF, Middle Aged, Heart Failure/diagnosis, hsCRP, GDF15, Diabetes Mellitus, Type 2, Double-Blind Method, Glucosides, Humans, Female, Benzhydryl Compounds, hsTNT, Cardiology and Cardiovascular Medicine, Sodium-Glucose Transporter 2 Inhibitors, SGLT2 inhibitors, Biomarkers, Aged
وصف الملف: application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2b6a6412bbe3d1e4c11f80b5b70b561
https://findresearcher.sdu.dk:8443/ws/files/199867422/s12933_022_01463_2_1_.pdf -
4
المؤلفون: Soo Kun Lim, Ron T. Gansevoort, Claire C J Dekkers, Abdul Halim Abdul Gafor, Hiddo J.L. Heerspink, David Z.I. Cherney, Gian Luca Di Tanna, Diamond investigators, Muh Geot Wong, Heather N. Reich, Peter J. Greasley, Marc G. Vervloet, Daniel C. Cattran, Sean J. Barbour, Gozewijn D. Laverman
المساهمون: Groningen Kidney Center (GKC), Cardiovascular Centre (CVC), Real World Studies in PharmacoEpidemiology, -Genetics, -Economics and -Therapy (PEGET), Nephrology, ACS - Diabetes & metabolism, AII - Inflammatory diseases
المصدر: Lancet Diabetes & Endocrinology, 8(7), 582-593. ELSEVIER SCIENCE INC
DIAMOND investigators 2020, ' Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non-diabetic patients with chronic kidney disease (DIAMOND) : a randomised, double-blind, crossover trial ', Lancet diabetes & endocrinology, vol. 8, no. 7, pp. 582-593 . https://doi.org/10.1016/S2213-8587(20)30162-5
Lancet diabetes & endocrinology, 8(7), 582-593. Elsevier BVمصطلحات موضوعية: Male, Endocrinology, Diabetes and Metabolism, Benzhydryl Compounds/adverse effects, Type 2 diabetes, Biomarkers/analysis, chemistry.chemical_compound, 0302 clinical medicine, Endocrinology, Glucosides, Renal Insufficiency, Prospective Studies, 030212 general & internal medicine, Dapagliflozin, Netherlands, Cross-Over Studies, Incidence, Middle Aged, Prognosis, Proteinuria, Female, medicine.symptom, Glomerular Filtration Rate, Adult, Canada, medicine.medical_specialty, Adolescent, Canada/epidemiology, Urology, Renal function, Netherlands/epidemiology, 030209 endocrinology & metabolism, Placebo, Chronic/drug therapy, Glucosides/adverse effects, Proteinuria/chemically induced, Young Adult, 03 medical and health sciences, Double-Blind Method, Diabetes mellitus, Internal Medicine, medicine, Humans, Benzhydryl Compounds, Renal Insufficiency, Chronic, Sodium-Glucose Transporter 2 Inhibitors, Aged, Renal Insufficiency, Chronic/drug therapy, business.industry, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, medicine.disease, Crossover study, chemistry, Albuminuria, business, Biomarkers, Follow-Up Studies, Kidney disease
وصف الملف: application/pdf
-
5
المؤلفون: Lu, H., Hullin, R., Yerly, P., Meyer, P., Kosinski, C., Daux, A.
المصدر: Revue medicale suisse, vol. 17, no. 740, pp. 1034-1038
مصطلحات موضوعية: Benzhydryl Compounds/adverse effects, Cardiovascular Diseases/chemically induced, Diabetes Mellitus, Type 2/drug therapy, Heart Failure, Humans, Hypoglycemic Agents/adverse effects, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Stroke Volume
وصف الملف: application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=od______1900::68472c38c8f1eb8f3f7a8a91d41b1767
https://serval.unil.ch/resource/serval:BIB_7FA860CBBECC.P001/REF.pdf -
6
المؤلفون: Evgeny Moshkovich, Kārlis Trušinskis, Guntram Schernthaner, Marju Past, Katarina Lalic, Susanne Kaser, Agnė Abraitienė, Gabriela Radulian, Janusz Gumprecht, Martin Prázný, Alexander S. Ametov, Zsolt Gaàl, Avraham Karasik, Ivan Tkáč, Boris Mankovsky, Andrej Janež, Lea Duvnjak
المصدر: Cardiovascular Diabetology, Vol 18, Iss 1, Pp 1-9 (2019)
Cardiovascular Diabetology
Cardiovascular diabetology, London : BioMed Central, 2019, vol. 18, no. 1, art. no. 115, p. 2461-2498مصطلحات موضوعية: Research design, lcsh:Diseases of the circulatory (Cardiovascular) system, CVOTs, EMPA-REG OUTCOME, EMPRISE, heart failure, real-world evidence, type 2 diabetes, Endocrinology, Diabetes and Metabolism, Diabetes Mellitus, Type 2 / diagnosis, Disease, 030204 cardiovascular system & hematology, Sodium-Glucose Transporter 2 Inhibitors / therapeutic use, 0302 clinical medicine, Glucosides, Risk Factors, Practice Patterns, Physicians', Diabetes Mellitus, Type 2 / mortality, Real-world evidence, Clinical Trials as Topic, Evidence-Based Medicine, Type 2 diabetes, 3. Good health, Hospitalization, Cardiovascular Diseases / diagnosis, Treatment Outcome, Cardiovascular Diseases, Research Design, Practice Guidelines as Topic, Cardiology and Cardiovascular Medicine, Risk assessment, medicine.medical_specialty, Clinical Decision-Making, 030209 endocrinology & metabolism, Context (language use), Heart failure, Risk Assessment, Glucosides / therapeutic use, 03 medical and health sciences, Sodium-Glucose Transporter 2 Inhibitors / adverse effects, Internal medicine, medicine, Empagliflozin, Humans, Benzhydryl Compounds, Intensive care medicine, Sodium-Glucose Transporter 2 Inhibitors, business.industry, Cardiovascular Diseases / therapy, Perspective (graphical), Evidence-based medicine, Clinical Trials as Topic / methods, Protective Factors, Interim analysis, Glucosides / adverse effects, Benzhydryl Compounds / adverse effects, Cardiovascular Diseases / mortality, Diabetes Mellitus, Type 2, Benzhydryl Compounds / therapeutic use, lcsh:RC666-701, Commentary, business, Diabetes Mellitus, Type 2 / drug therapy
وصف الملف: application/pdf
-
7
المؤلفون: Finn Gustafsson, Emil L. Fosbøl, Mikael Kjær Poulsen, Christian Tuxen, Caroline Kistorp, Morten Schou, Lars Videbæk, Ida Gustafsson, Peter H. Frederiksen, Lars Køber, Jesper Jensen, Niels Eske Bruun, Massar Omar, Jacob E. Møller
المصدر: Trials, Vol 20, Iss 1, Pp 1-8 (2019)
Jensen, J, Omar, M, Kistorp, C, Poulsen, M K, Tuxen, C, Gustafsson, I, Køber, L, Gustafsson, F, Fosbøl, E, Bruun, N E, Videbæk, L, Frederiksen, P H, Møller, J E & Schou, M 2019, ' Empagliflozin in heart failure patients with reduced ejection fraction : a randomized clinical trial (Empire HF) ', Trials, vol. 20, 374 . https://doi.org/10.1186/s13063-019-3474-5
Jensen, J, Omar, M, Kistorp, C, Poulsen, M K, Tuxen, C, Gustafsson, I, Køber, L, Gustafsson, F, Fosbøl, E, Bruun, N E, Videbæk, L, Frederiksen, P H, Møller, J E & Schou, M 2019, ' Empagliflozin in heart failure patients with reduced ejection fraction : a randomized clinical trial (Empire HF) ', Trials, vol. 20, no. 1, 374 . https://doi.org/10.1186/s13063-019-3474-5
Trials
Jensen, J, Omar, M, Kistorp, C, Poulsen, M K, Tuxen, C, Gustafsson, I, Køber, L, Gustafsson, F, Fosbøl, E, Bruun, N E, Videbæk, L, Frederiksen, P H, Møller, J E & Schou, M 2019, ' Empagliflozin in heart failure patients with reduced ejection fraction : A randomized clinical trial (Empire HF) ', Trials, vol. 20, 374 . https://doi.org/10.1186/s13063-019-3474-5مصطلحات موضوعية: Benzhydryl Compounds/adverse effects, Medicine (miscellaneous), Type 2 diabetes, law.invention, Study Protocol, 0302 clinical medicine, Glucosides, Randomized controlled trial, law, Natriuretic Peptide, Brain, Pharmacology (medical), 030212 general & internal medicine, lcsh:R5-920, Ejection fraction, Mode of action, Cardiology, Mechanism, lcsh:Medicine (General), SGLT2 inhibitors, Renal endpoints, Quality of life, Cardiac function curve, medicine.medical_specialty, Heart failure, Daily activity level, Placebo, Glucosides/adverse effects, 03 medical and health sciences, Double-Blind Method, Internal medicine, medicine, Empagliflozin, Humans, Benzhydryl Compounds, Sodium-Glucose Transporter 2 Inhibitors, business.industry, Diabetes Mellitus, Type 2/complications, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Cardiac function, Stroke Volume, medicine.disease, Heart Failure/drug therapy, Peptide Fragments, Clinical trial, Diabetes Mellitus, Type 2, NT-proBNP, Quality of Life, Stroke Volume/drug effects, Metabolic endpoints, Natriuretic Peptide, Brain/blood, business, Peptide Fragments/blood, 030217 neurology & neurosurgery
وصف الملف: application/pdf
-
8
المؤلفون: David C. Wheeler, Tom Greene, John J.V. McMurray, Hiddo J.L. Heerspink, Robert D. Toto, Anna Maria Langkilde, Glenn M. Chertow, Bergur V. Stefánsson, Fan Fan Hou, Ricardo Correa-Rotter, Dapa-Ckd Trial Committees, Investigators, Peter Rossing, C. David Sjöström, Niels Jongs
المساهمون: Real World Studies in PharmacoEpidemiology, -Genetics, -Economics and -Therapy (PEGET), Groningen Kidney Center (GKC)
المصدر: Lancet Diabetes & Endocrinology, 9(1), 22-31. ELSEVIER SCIENCE INC
DAPA-CKD Trial Committees and Investigators 2021, ' Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease : a prespecified analysis from the DAPA-CKD trial ', The Lancet Diabetes and Endocrinology, vol. 9, no. 1, pp. 22-31 . https://doi.org/10.1016/S2213-8587(20)30369-7مصطلحات موضوعية: Male, Endocrinology, Diabetes and Metabolism, Benzhydryl Compounds/adverse effects, Type 2 diabetes, Kidney/drug effects, Kidney, Kidney Failure, Diabetic nephropathy, chemistry.chemical_compound, 0302 clinical medicine, Endocrinology, Glucosides, Kidney Failure, Chronic/chemically induced, Diabetic Nephropathies, Renal Insufficiency, 030212 general & internal medicine, Dapagliflozin, Middle Aged, Cardiovascular Diseases/chemically induced, Type 2/complications, Treatment Outcome, Cardiovascular Diseases, Female, Adult, Chronic/complications, medicine.medical_specialty, Renal Insufficiency, Chronic/complications, Renal function, 030209 endocrinology & metabolism, Glucosides/adverse effects, 03 medical and health sciences, Chronic/chemically induced, Double-Blind Method, Diabetes mellitus, Internal medicine, Diabetes Mellitus, Internal Medicine, medicine, Humans, Benzhydryl Compounds, Renal Insufficiency, Chronic, Adverse effect, Heart Failure/chemically induced, Aged, Heart Failure, business.industry, Diabetes Mellitus, Type 2/complications, medicine.disease, Diabetes Mellitus, Type 2, chemistry, Heart failure, Diabetic Nephropathies/drug therapy, Kidney Failure, Chronic, business, Kidney disease
وصف الملف: application/pdf
-
9
المؤلفون: Heerspink, Hiddo J.L., Stefánsson, Bergur V., Correa-Rotter, Ricardo, Chertow, Glenn M., Greene, Tom, Hou, Fan-Fan, Mann, Johannes F.E., McMurray, John J.V., Lindberg, Magnus, Rossing, Peter, Sjöström, C. David, Toto, Roberto D., Langkilde, Anna-Maria, Wheeler, David C., Cruzado, Josep Ma.
المساهمون: Real World Studies in PharmacoEpidemiology, -Genetics, -Economics and -Therapy (PEGET), Groningen Kidney Center (GKC)
المصدر: New England Journal of Medicine, 383(15), 1436-1446. MASSACHUSETTS MEDICAL SOC
Heerspink, H J L, Stefánsson, B V, Correa-Rotter, R, Chertow, G M, Greene, T, Hou, F-F, Mann, J F E, McMurray, J J V, Lindberg, M, Rossing, P, Sjöström, C D, Toto, R D, Langkilde, A-M, Wheeler, D C & DAPA-CKD Trial Committees and Investigators 2020, ' Dapagliflozin in Patients with Chronic Kidney Disease ', The New England Journal of Medicine, vol. 383, no. 15, pp. 1436-1446 . https://doi.org/10.1056/NEJMoa2024816
Dipòsit Digital de la UB
Universidad de Barcelonaمصطلحات موضوعية: Male, Kidney Failure, Chronic/mortality, Benzhydryl Compounds/adverse effects, Kaplan-Meier Estimate, 030204 cardiovascular system & hematology, Glomerular Filtration Rate/drug effects, law.invention, chemistry.chemical_compound, 0302 clinical medicine, Randomized controlled trial, Glucosides, law, Diabetic Nephropathies, 030212 general & internal medicine, Dapagliflozin, Kidney, Diabetis, Kidney diseases, Diabetes, EMPAGLIFLOZIN, General Medicine, Middle Aged, medicine.anatomical_structure, Cardiovascular Diseases, Regression Analysis, Female, Glomerular Filtration Rate, medicine.medical_specialty, Finerenone, Renal Insufficiency, Chronic/complications, CARDIOVASCULAR OUTCOMES, Glucosides/adverse effects, 03 medical and health sciences, Internal medicine, Diabetes mellitus, Empagliflozin, medicine, Humans, Benzhydryl compounds, Cardiovascular Diseases/etiology, Benzhydryl Compounds, Renal Insufficiency, Chronic, Sodium-Glucose Transporter 2 Inhibitors, Aged, urogenital system, business.industry, Diabetes Mellitus, Type 2/complications, Glucòsids, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, medicine.disease, Diabetes Mellitus, Type 2, chemistry, Diabetic Nephropathies/drug therapy, Kidney Failure, Chronic, Malalties del ronyó, business, Kidney disease
وصف الملف: application/pdf
-
10
المؤلفون: Butt, Jawad H., Adamson, Carly, Docherty, Kieran F., de Boer, Rudolf A., Petrie, Mark C., Inzucchi, Silvio E., Kosiborod, Mikhail N., Maria Langkilde, Anna, Lindholm, Daniel, Martinez, Felipe A., Bengtsson, Olof, Schou, Morten, O’Meara, Eileen, Ponikowski, Piotr, Sabatine, Marc S., Sjostrand, Mikaela, Solomon, Scott D., Jhund, Pardeep S., McMurray, John J. V., Kober, Lars
المصدر: Circulation. Heart failure. 14(12)
مصطلحات موضوعية: Aged, Atrial Fibrillation/drug therapy/physiopathology, Benzhydryl Compounds/*adverse effects/*therapeutic use, clinical trials, Clinical Trials as Topic, Glucosides/*adverse effects/*therapeutic use, heart failure with reduced ejection fraction, Heart Failure/*drug therapy/physiopathology, Hospitalization/statistics & numerical data, Humans, Male, Middle Aged, Natriuretic Peptide, Brain/*therapeutic use, natriuretic peptides, Peptide Fragments/*therapeutic use, sodium-glucose cotransporter 2 inhibitors, Stroke Volume/drug effects, Ventricular Function, Left/drug effects
وصف الملف: print
Full Text via ClinicalKey 
Find this article in full text from Springer Verlag.